196 related articles for article (PubMed ID: 15324473)
1. Impact of a co-factor on the dynamics of Leishmania donovani infection: does HIV infection encourage the recurrence of visceral leishmaniasis following post-kala-azar dermal leishmaniasis?
Nandy A; Addy M; Maji AK; Guha SK
Ann Trop Med Parasitol; 2004 Sep; 98(6):651-4. PubMed ID: 15324473
[No Abstract] [Full Text] [Related]
2. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
[TBL] [Abstract][Full Text] [Related]
3. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
[TBL] [Abstract][Full Text] [Related]
4. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
[TBL] [Abstract][Full Text] [Related]
5. Post-kala-azar dermal leishmaniasis in HIV-coinfected individuals: problems in diagnosis and treatment.
Ramesh V; Avishek K; Salotra P
Int J Dermatol; 2015 Jan; 54(1):116-20. PubMed ID: 25209701
[No Abstract] [Full Text] [Related]
6. Atypical disseminated leishmaniasis similar to post-kala-azar dermal leishmaniasis in a Brazilian AIDS patient infected with Leishmania (Leishmania) infantum chagasi: a case report.
Carnaúba D; Konishi CT; Petri V; Martinez IC; Shimizu L; Pereira-Chioccola VL
Int J Infect Dis; 2009 Nov; 13(6):e504-7. PubMed ID: 19447660
[TBL] [Abstract][Full Text] [Related]
7. Kala-azar and post-kala-azar dermal leishmaniasis, Assam, India.
Khan AM; Dutta P; Khan SA; Baruah SK; Raja D; Khound K; Mahanta J
Emerg Infect Dis; 2014 Mar; 20(3):487-9. PubMed ID: 24565057
[No Abstract] [Full Text] [Related]
8. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
9. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
[TBL] [Abstract][Full Text] [Related]
10. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
[No Abstract] [Full Text] [Related]
11. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
[TBL] [Abstract][Full Text] [Related]
12. Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis.
Ansari NA; Ramesh V; Salotra P
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1160-2. PubMed ID: 18639311
[TBL] [Abstract][Full Text] [Related]
13. Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient.
Abongomera C; Battaglioli T; Adera C; Ritmeijer K
Int J Infect Dis; 2019 Apr; 81():221-224. PubMed ID: 30790722
[TBL] [Abstract][Full Text] [Related]
14. An unusual case of post-kala-azar dermal leishmaniasis in a patient with HIV and visceral leishmaniasis co-infection.
Elliott T; Simpson J; Naresh KN; Lockwood D; Bailey AC
Int J STD AIDS; 2019 Oct; 30(12):1221-1223. PubMed ID: 31558131
[No Abstract] [Full Text] [Related]
15. Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine.
Monge-Maillo B; Norman FF; Chamorro-Tojeiro S; Gioia F; Pérez-Molina JA; Chicharro C; Moreno J; López-Vélez R
J Travel Med; 2022 Nov; 29(7):. PubMed ID: 34668558
[No Abstract] [Full Text] [Related]
16. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
[TBL] [Abstract][Full Text] [Related]
17. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
Ramesh V
Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
[No Abstract] [Full Text] [Related]
18. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
19. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
20. Post-Kala-azar dermal leishmaniasis due to Leishmania donovani in Europe--case report.
Antunes J; da Costa JB; Guimarães M; Vaz-Pinto I; Soares-Almeida L; Filipe P
Int J Dermatol; 2013 Dec; 52(12):1584-6. PubMed ID: 24261735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
